
We present a case of an 18-year-old male patient who, after two years of inappropriate treatment for cutaneous leishmaniasis, began to show nodules arising at the edges of the former healing scar. He was immune competent and denied any trauma. The diagnosis of recurrent cutaneous leishmaniasis was made following positive culture of aspirate samples. The patient was treated with N-methylglucamine associated with pentoxifylline for 30 days. Similar cases require special attention mainly because of the challenges imposed by treatment.
Leishmaniasis, mucocutaneous, Male, Imaging In Tropical Dermatology, Adolescent, Antiprotozoal Agents, Leishmaniasis, Cutaneous, Terapeutica, Therapeutics, Pentoxifilina, Meglumine, Treatment Outcome, Recurrence, Leishmaniose, Humans, Leishmaniose mucocutanea, Drug Therapy, Combination, Pentoxifylline, Leishmaniasis, Recidiva
Leishmaniasis, mucocutaneous, Male, Imaging In Tropical Dermatology, Adolescent, Antiprotozoal Agents, Leishmaniasis, Cutaneous, Terapeutica, Therapeutics, Pentoxifilina, Meglumine, Treatment Outcome, Recurrence, Leishmaniose, Humans, Leishmaniose mucocutanea, Drug Therapy, Combination, Pentoxifylline, Leishmaniasis, Recidiva
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
